ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
64,205.36
2.09%
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs Yen
153.055
0.01%
Brent Oil
82.765
0.00%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. NeuroOne Medical Technologies Corporation (NMTC)

  7. NeuroOne Medical Technologies Corporation (NMTC) ニュース

NMTC NeuroOne Medical Technologies Corporation

1.1899
-0.0201 (-1.66%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
NeuroOne Medical Technologies Corporation NMTC NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
-0.0201 -1.66% 1.1899 08:19:56
始値 安値 高値 終値 前日終値
1.23 1.15 1.231 1.17 1.21
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/1022:00GLOBENeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
2024/4/0922:05GLOBENeuroOne® Announces First Implant of OneRF™ Ablation..
2024/4/0422:00GLOBENeuroOne® CEO Dave Rosa Featured on Fox Business Network’s..
2024/3/2622:00GLOBENeuroOne® Initiates Limited Commercial Launch of OneRF™..
2024/3/0902:00GLOBENeuroOne® to Participate in the 36th Annual Roth Conference
2024/3/0504:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0504:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0503:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2407:10GLOBENeuroOne Reports Inducement Grant Under Nasdaq Listing Rule..
2024/2/2201:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2200:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2200:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2200:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1406:15EDGAR2Form 8-K - Current report
2024/2/1406:00GLOBENeuroOne® Reports First Quarter Fiscal Year 2024 Financial..
2024/2/0905:30GLOBENeuroOne® to Report First Quarter Fiscal Year 2024 Financial..
2024/2/0203:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0203:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0203:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0106:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/1/2923:02EDGAR2Form ARS - Annual Report to Security Holders
2024/1/2923:00EDGAR2Form DEF 14A - Other definitive proxy statements
2024/1/0606:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/0403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0403:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0403:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2808:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2706:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2706:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2123:35EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1606:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/12/1606:39EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2023/12/1506:30EDGAR2Form 8-K - Current report
2023/12/1506:15GLOBENeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year..
2023/12/1122:15EDGAR2Form 8-K - Current report
2023/12/1122:00GLOBENeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™..
2023/12/0806:30GLOBENeuroOne® to Report Fourth Quarter and Fiscal Year 2023..
2023/12/0506:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0506:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0506:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0206:55EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/11/1622:00EDGAR2Form 8-K - Current report
2023/11/1622:00GLOBENeuroOne® Announces Patent Allowance for Drug Delivery..
2023/11/1507:15GLOBENeuroOne® Appoints Medtech Executive Christopher R. Volker..
2023/11/1408:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1407:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1407:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0722:15EDGAR2Form 8-K - Current report
2023/11/0722:00GLOBENeuroOne® Provides Progress Update on FDA 510(k) Submission..

最近閲覧した銘柄

NASDAQ
NMTC
NeuroOne Medical Technol...
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有